Hans W. Ruelius

2.0k total citations
71 papers, 1.5k citations indexed

About

Hans W. Ruelius is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, Hans W. Ruelius has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 21 papers in Pharmacology and 14 papers in Analytical Chemistry. Recurrent topics in Hans W. Ruelius's work include Pharmacogenetics and Drug Metabolism (15 papers), Analytical Chemistry and Chromatography (12 papers) and Analytical Methods in Pharmaceuticals (12 papers). Hans W. Ruelius is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Analytical Chemistry and Chromatography (12 papers) and Analytical Methods in Pharmaceuticals (12 papers). Hans W. Ruelius collaborates with scholars based in United States, Canada and Germany. Hans W. Ruelius's co-authors include Frank W. Janssen, Samuel F. Sisenwine, John A. Knowles, Sandra K. Kirkman, David J. Greenblatt, Richard I. Shader, Catherine Fenselau, Mohamed El Mouelhi, Deanne M. Dulik and Adeline Gauhe and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Hans W. Ruelius

70 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans W. Ruelius United States 23 403 314 294 170 151 71 1.5k
L. P. C. Delbressine Netherlands 19 422 1.0× 297 0.9× 306 1.0× 235 1.4× 143 0.9× 39 1.7k
H. Hücker United States 19 371 0.9× 357 1.1× 447 1.5× 189 1.1× 198 1.3× 59 1.6k
D. Loew Germany 22 284 0.7× 258 0.8× 304 1.0× 118 0.7× 179 1.2× 106 1.7k
H. J. Dengler Germany 22 660 1.6× 586 1.9× 364 1.2× 114 0.7× 323 2.1× 69 2.4k
U. Breyer-Pfaff Germany 20 357 0.9× 383 1.2× 291 1.0× 110 0.6× 118 0.8× 55 1.1k
Don W. Shoeman United States 25 539 1.3× 334 1.1× 165 0.6× 117 0.7× 248 1.6× 58 2.0k
Marcel H. Bickel Switzerland 28 699 1.7× 547 1.7× 367 1.2× 235 1.4× 255 1.7× 94 2.1k
Ronald B. Franklin United States 24 550 1.4× 569 1.8× 173 0.6× 309 1.8× 98 0.6× 80 1.8k
Brodie Bb 12 389 1.0× 254 0.8× 172 0.6× 89 0.5× 161 1.1× 19 1.4k
Marvin D. Armstrong United States 28 986 2.4× 130 0.4× 180 0.6× 278 1.6× 208 1.4× 62 2.9k

Countries citing papers authored by Hans W. Ruelius

Since Specialization
Citations

This map shows the geographic impact of Hans W. Ruelius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans W. Ruelius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans W. Ruelius more than expected).

Fields of papers citing papers by Hans W. Ruelius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans W. Ruelius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans W. Ruelius. The network helps show where Hans W. Ruelius may publish in the future.

Co-authorship network of co-authors of Hans W. Ruelius

This figure shows the co-authorship network connecting the top 25 collaborators of Hans W. Ruelius. A scholar is included among the top collaborators of Hans W. Ruelius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans W. Ruelius. Hans W. Ruelius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wells, David S., Frank W. Janssen, & Hans W. Ruelius. (1987). Interactions between oxaprozin glucuronide and human serum albumin. Xenobiotica. 17(12). 1437–1449. 42 indexed citations
2.
Mouelhi, Mohamed El, Hans W. Ruelius, Catherine Fenselau, & Deanne M. Dulik. (1987). Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen.. Drug Metabolism and Disposition. 15(6). 767–772. 65 indexed citations
3.
Ruelius, Hans W., et al.. (1986). Reactions of Oxaprozin-1-0-Acyl Glucuronide in Solutions of Human Plasma and Albumin. Advances in experimental medicine and biology. 197. 431–441. 44 indexed citations
4.
Sisenwine, Samuel F., et al.. (1983). Determination of Ciramadol in Plasma by Gas–Liquid Chromatography. Journal of Pharmaceutical Sciences. 72(1). 85–87. 3 indexed citations
5.
Sisenwine, Samuel F., et al.. (1982). Metabolic disposition of ciramadol in rhesus monkeys and rats.. Drug Metabolism and Disposition. 10(2). 161–167. 6 indexed citations
6.
Sisenwine, Samuel F., et al.. (1981). Pharmacokinetic disposition of guanabenz in the rhesus monkey.. Drug Metabolism and Disposition. 9(6). 509–514. 6 indexed citations
7.
Ruelius, Hans W., et al.. (1980). Relationship of guanabenz concentrations in brain and plasma to antihypertensive effect in the spontaneously hypertensive rat.. Journal of Pharmacology and Experimental Therapeutics. 214(3). 594–598. 19 indexed citations
8.
Janssen, Frank W., et al.. (1980). Metabolism and kinetics of oxaprozin in normal subjects. Clinical Pharmacology & Therapeutics. 27(3). 352–362. 36 indexed citations
9.
Ruelius, Hans W., et al.. (1979). Diastereoisomeric glucuronides of oxazepam. Isolation and stereoselective enzymic hydrolysis.. Drug Metabolism and Disposition. 7(1). 40–43. 34 indexed citations
10.
Sisenwine, Samuel F., et al.. (1979). The metabolic disposition of norgestrel in female rhesus monkeys.. Drug Metabolism and Disposition. 7(1). 1–6. 7 indexed citations
11.
Greenblatt, David J., et al.. (1977). Clinical Pharmacokinetics of Lorazepam. III. Intravenous Injection. Preliminary Results. The Journal of Clinical Pharmacology. 17(8-9). 490–494. 30 indexed citations
12.
Greenblatt, David J., et al.. (1976). Clinical pharmacokinetics of lorazepam. Clinical Pharmacology & Therapeutics. 20(3). 329–341. 80 indexed citations
13.
Sisenwine, Samuel F., et al.. (1975). LORAZEPAM: GLUCURONIDE FORMATION IN THE CAT. Drug Metabolism and Disposition. 3(2). 85–88. 9 indexed citations
14.
Ruelius, Hans W.. (1975). Interaction of Drug Metabolism with the Other Elements of Drug Safety Evaluation. Drug Metabolism Reviews. 4(1). 115–133. 3 indexed citations
15.
Sisenwine, Samuel F., et al.. (1974). Stereoselective biotransformations of dl-norgestrel and its enantiomers in the African green monkey.. PubMed. 2(1). 65–70. 8 indexed citations
16.
Sisenwine, Samuel F. & Hans W. Ruelius. (1971). PLASMA CONCENTRATIONS AND URINARY EXCRETION OF ISOSORBIDE DINITRATE AND ITS METABOLITES IN THE DOG. Journal of Pharmacology and Experimental Therapeutics. 176(2). 296–301. 44 indexed citations
17.
Janssen, Frank W., et al.. (1965). Alcohol oxidase, a novel enzyme from a basidiomycete. Biochemical and Biophysical Research Communications. 20(5). 630–634. 30 indexed citations
18.
Gauhe, Adeline, Paul György, John R. E. Hoover, et al.. (1954). Bifidus factor. IV. Preparations obtained from human milk. Archives of Biochemistry and Biophysics. 48(1). 214–224. 89 indexed citations
19.
Ruelius, Hans W., et al.. (1954). Occurrence of galactosamine in human milk. Archives of Biochemistry and Biophysics. 50(2). 512–513. 6 indexed citations
20.
Ruelius, Hans W. & Adeline Gauhe. (1951). Isolierung und Konstitution eines Hydrojuglon‐glucosids aus den grünen Schalen der Walnuß. Justus Liebig s Annalen der Chemie. 571(1). 69–75. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. P. C. Delbressine Breakdown of academic impact, for papers by H. Hücker Breakdown of academic impact, for papers by D. Loew Breakdown of academic impact, for papers by H. J. Dengler Breakdown of academic impact, for papers by U. Breyer-Pfaff Breakdown of academic impact, for papers by Don W. Shoeman Breakdown of academic impact, for papers by Marcel H. Bickel Breakdown of academic impact, for papers by Ronald B. Franklin Breakdown of academic impact, for papers by Brodie Bb Breakdown of academic impact, for papers by Marvin D. Armstrong
Rankless by CCL
2026